Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
2.010
+0.050 (2.55%)
Jun 4, 2026, 4:00 PM EDT - Market closed
Protalix BioTherapeutics Employees
Protalix BioTherapeutics had 226 employees as of December 31, 2025. The number of employees increased by 13 or 6.10% compared to the previous year.
Employees
226
Change (1Y)
13
Growth (1Y)
6.10%
Revenue / Employee
$337,969
Profits / Employee
$67,841
Market Cap
161.95M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 226 | 13 | 6.10% | 226 | 0 |
| Dec 31, 2024 | 213 | 5 | 2.40% | 213 | 0 |
| Dec 31, 2023 | 208 | 11 | 5.58% | 208 | 0 |
| Dec 31, 2022 | 197 | -9 | -4.37% | 193 | 4 |
| Dec 31, 2021 | 206 | -1 | -0.48% | 202 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 164 |
| Heron Therapeutics | 128 |
| MediWound | 121 |
| OnKure Therapeutics | 45 |
| Jyong Biotech | 27 |
| Spero Therapeutics | 25 |
| Canton Strategic Holdings | 12 |
| Galectin Therapeutics | 9 |
PLX News
- 22 days ago - Protalix BioTherapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 22 days ago - Protalix BioTherapeutics Earnings release: Q1 2026 - Filings
- 22 days ago - Protalix BioTherapeutics Quarterly report: Q1 2026 - Filings
- 22 days ago - Protalix BioTherapeutics Slides: Corporate presentation - Filings
- 22 days ago - Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results - PRNewsWire
- 4 weeks ago - Protalix BioTherapeutics to Announce First Quarter 2026 Financial Results and Business Update on May 13, 2026 - PRNewsWire
- 5 weeks ago - Protalix BioTherapeutics Proxy statement: Proxy filing - Filings
- 2 months ago - Protalix BioTherapeutics Earnings Call Transcript: Q4 2025 - Transcripts